Polycystic Ovary Syndrome Clinical Trials 
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.Effects of Combined Metformin and Cabergoline in Comparison With Metformin Only Therapy on Ovarian and Hormonal Activities in Iraqi Patients With PCOS
Condition: Polycystic Ovary Syndrome Interventions: Drug: Metformin Hydrochloride 500 MG; Drug: Cabergoline 0.5 MG; Drug: Metformin Hydrochloride 500 MG + Cabergoline 0.5 MG Sponsor: Al-Rasheed University College Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2023 Category: Research Source Type: clinical trials
The Psychological and Social Impact of PCOS
Condition: Polycystic Ovary Syndrome Intervention: Other: Questionnaire Sponsor: University Hospital, Lille Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2023 Category: Research Source Type: clinical trials
Effects of Combined Metformin and Cabergoline in Comparison With Metformin Only Therapy on Ovarian and Hormonal Activities in Iraqi Patients With PCOS
Condition: Polycystic Ovary Syndrome Interventions: Drug: Metformin Hydrochloride 500 MG; Drug: Cabergoline 0.5 MG; Drug: Metformin Hydrochloride 500 MG + Cabergoline 0.5 MG Sponsor: Al-Rasheed University College Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2023 Category: Research Source Type: clinical trials
The Psychological and Social Impact of PCOS
Condition: Polycystic Ovary Syndrome Intervention: Other: Questionnaire Sponsor: University Hospital, Lille Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2023 Category: Research Source Type: clinical trials
Effects of Combined Metformin and Cabergoline in Comparison With Metformin Only Therapy on Ovarian and Hormonal Activities in Iraqi Patients With PCOS
Condition: Polycystic Ovary Syndrome Interventions: Drug: Metformin Hydrochloride 500 MG; Drug: Cabergoline 0.5 MG; Drug: Metformin Hydrochloride 500 MG + Cabergoline 0.5 MG Sponsor: Al-Rasheed University College Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2023 Category: Research Source Type: clinical trials
The Psychological and Social Impact of PCOS
Condition: Polycystic Ovary Syndrome Intervention: Other: Questionnaire Sponsor: University Hospital, Lille Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2023 Category: Research Source Type: clinical trials
Effects of Combined Metformin and Cabergoline in Comparison With Metformin Only Therapy on Ovarian and Hormonal Activities in Iraqi Patients With PCOS
Condition: Polycystic Ovary Syndrome Interventions: Drug: Metformin Hydrochloride 500 MG; Drug: Cabergoline 0.5 MG; Drug: Metformin Hydrochloride 500 MG + Cabergoline 0.5 MG Sponsor: Al-Rasheed University College Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2023 Category: Research Source Type: clinical trials
The Psychological and Social Impact of PCOS
Condition: Polycystic Ovary Syndrome Intervention: Other: Questionnaire Sponsor: University Hospital, Lille Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2023 Category: Research Source Type: clinical trials
Effects of Combined Metformin and Cabergoline in Comparison With Metformin Only Therapy on Ovarian and Hormonal Activities in Iraqi Patients With PCOS
Condition: Polycystic Ovary Syndrome Interventions: Drug: Metformin Hydrochloride 500 MG; Drug: Cabergoline 0.5 MG; Drug: Metformin Hydrochloride 500 MG + Cabergoline 0.5 MG Sponsor: Al-Rasheed University College Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 8, 2023 Category: Research Source Type: clinical trials
Bicalutamide Therapy in Young Women With NAFLD and PCOS
Conditions: NAFLD; PCOS Interventions: Drug: Bicalutamide 50 mg; Drug: Placebo Sponsors: University of California, San Francisco; National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 7, 2023 Category: Research Source Type: clinical trials
